Previous 10 | Next 10 |
The Chinese economy’s steady recovery and the impressive GDP growth expected there have whetted investors’ appetite for Chinese stocks. While current regulatory scrutiny of Chinese companies and tensions between Washington and Beijing have resulted in a retreat by stocks includi...
China Biologic Announces Shareholders' Approval of Merger Agreement PR Newswire BEIJING , March 1, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceut...
While China’s tech giants are facing strict regulatory supervision because of their alleged unfair competition, other Chinese stocks have been able to capitalize handsomely on the Chinese economy’s rapid recovery from the coronavirus pandemic. As the country’s economy con...
China Biologic Announces Extraordinary General Meeting of Shareholders PR Newswire BEIJING , Jan. 25, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmac...
Image source: The Motley Fool. China Biologic Products Inc (NASDAQ: CBPO) Q3 2020 Earnings Call Nov 26, 2020 , 7:30 p.m. ET Operator Continue reading For further details see: China Biologic Products Inc (CBPO) Q3 2020 Earnings Call Transc...
China Biologic Products Holdings, Inc. (CBPO) Q3 2020 Earnings Conference Call November 25, 2020 07:30 ET Company Participants Philip Lisio - Investor Relations Joseph Chow - President and Chief Executive Officer Ming Yin - Senior Vice President Conference Call Participants Jason Liu - Credit...
The following slide deck was published by China Biologic Products Holdings, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: China Biologic Products Holdings, Inc. 2020 Q3 - Results - Earnings Call Presentation
China Biologic Products (CBPO): Q3 Non-GAAP EPS of $1.40 beats by $0.12; GAAP EPS of $0.99.Revenue of $138.5M (+1.8% Y/Y)Press Release For further details see: China Biologic Products EPS beats by $0.12
China Biologic Reports Financial Results for the Third Quarter of 2020 PR Newswire BEIJING, Nov. 24, 2020 BEIJING , Nov. 24, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integra...
Merger activity increased last week with four new deals announced. The acquisition of HD Supply Holdings by The Home Depot. The acquisition of Foundation Building Materials by American Securities. For further details see: Merger Arbitrage Mondays - Home Depot B...
News, Short Squeeze, Breakout and More Instantly...
China Biologic Products Holdings Inc. Company Name:
CBPO Stock Symbol:
NASDAQ Market:
Leading English language training provider Meten Holding Group’s (METX) stock has soared 54.5% in price over the past month thanks to the company’s strategic collaboration with AGM Group Holdings. However, given the company’s negative profit margins and mixed financials, ...
Currently trading at less than $1, the shares of China-based BIMI International Medical’s (BIMI) have dipped 72.2% in price over the past year. So, given the company’s weak financials and poor profitability, will its stock be able to regain its momentum? Read more to find out. ...
China Biologic Announces Completion of Going Private Transaction PR Newswire BEIJING , April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmac...